KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to -$7.4 billion.

  • Abbott Laboratories' Enterprise Value rose 176.02% to -$7.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 billion, marking a year-over-year increase of 176.02%. This contributed to the annual value of -$7.7 billion for FY2024, which is 956.77% down from last year.
  • According to the latest figures from Q3 2025, Abbott Laboratories' Enterprise Value is -$7.4 billion, which was up 176.02% from -$7.0 billion recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Enterprise Value peaked at -$6.4 billion during Q1 2024, and registered a low of -$10.0 billion during Q4 2021.
  • In the last 5 years, Abbott Laboratories' Enterprise Value had a median value of -$7.9 billion in 2023 and averaged -$8.1 billion.
  • As far as peak fluctuations go, Abbott Laboratories' Enterprise Value plummeted by 13550.16% in 2021, and later skyrocketed by 3106.34% in 2024.
  • Quarter analysis of 5 years shows Abbott Laboratories' Enterprise Value stood at -$10.0 billion in 2021, then grew by 0.76% to -$10.0 billion in 2022, then rose by 29.1% to -$7.1 billion in 2023, then dropped by 9.57% to -$7.7 billion in 2024, then grew by 3.97% to -$7.4 billion in 2025.
  • Its last three reported values are -$7.4 billion in Q3 2025, -$7.0 billion for Q2 2025, and -$6.6 billion during Q1 2025.